D1-5-((2-BENZYL-3,4-DIHYDRO-2H-BENZOPYRAN-6-YL)METHYL) THIAZOLIDINE-2,4-DIONE AS AN ANTI-ATHEROSCLEROSIS AGENT

D1-5-((2-BENZYL-3,4-DIHYDRO-2H-BENZOPYRAN-6-YL)METHYL) THIAZOLIDINE-2,4-DIONE AS AN ANTI-ATHEROSCLEROSIS AGENT

PATENT PC 7301 dl-5-¢(2-BENZYL-3,4-DIHYDRO-2H-BENZOPYRAN- 6-YL)METHYL!THIAZOLIDINE-2,4-DIONE AS AN ANTI-ATHEROSCLEROSIS AGENT. This invention relates of the use of a certain thiazolidine-2,4-dione, namely, dl-5-¢(2-benzyl-3,4-dihydro-2H-benzopyran-6-yl)methyl!thiazolidine-2,4-dione, or a pharmaceuti...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KRUPP, MICHAEL N, SWINDELL, ARCHIE C
Format: Patent
Sprache:eng ; fre
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:PATENT PC 7301 dl-5-¢(2-BENZYL-3,4-DIHYDRO-2H-BENZOPYRAN- 6-YL)METHYL!THIAZOLIDINE-2,4-DIONE AS AN ANTI-ATHEROSCLEROSIS AGENT. This invention relates of the use of a certain thiazolidine-2,4-dione, namely, dl-5-¢(2-benzyl-3,4-dihydro-2H-benzopyran-6-yl)methyl!thiazolidine-2,4-dione, or a pharmaceutically acceptable cationic salt thereof, for retarding the development of arterial disease in mammals. More specifically, it relates to a method for reducing the serum cholesterol levels in mammals by administering to said mammals dl-5-¢(2-benzyl-3,4-dihydro-2H-benzopyran-6-yl)methyl!-thiazolidine-2,4-dione or a pharmaceutically acceptable cationic salt thereof.